TY  - JOUR
AU  - Driessen, M T
AU  - Whalen, J
AU  - Buguth, B Seewoodharry
AU  - Vallejo-Aparicio, L A
AU  - Naya, I P
AU  - Asukai, Y
AU  - Alcázar-Navarrete, B
AU  - Miravitlles, M
AU  - García-Río, F
AU  - Risebrough, N A
PY  - 2019
DO  - 10.1186/s12931-019-0985-2
UR  - http://hdl.handle.net/10668/13475
T2  - Respiratory research
AB  - Following publication of the original article [1], we have been notified of the below corrections to the 5th paragraph in the Discussion section.
LA  - en
TI  - Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
TY  - research article
VL  - 20
ER  -